Moderna
MRNA
#1601
Rank
A$16.44 B
Marketcap
$42.54
Share price
-0.62%
Change (1 day)
-73.86%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$5.06 Billion

According to Moderna 's latest financial reports the company's total liabilities are A$5.06 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$5.21 B-22.35%
2023-12-31A$6.71 B-32.2%
2022-12-31A$9.89 B-31.82%
2021-12-31A$14.51 B133.71%
2020-12-31A$6.21 B948.87%
2019-12-31A$0.59 B-3.41%
2018-12-31A$0.61 B4.24%
2017-12-31A$0.58 B-26.3%
2016-12-31A$0.79 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$12.14 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$110.55 B 2,082.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$68.49 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.52 B 28.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$90.84 B 1,693.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$1.49 B-70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$169.76 B 3,251.25%๐Ÿ‡บ๐Ÿ‡ธ USA